Latest News

  • The real threat to NHS data isn’t technology: It’s misinformation that undermines performance and productivity

    By Alasdair Craine The debate around NHS data has drifted into something unrecognisable. What should be a grounded, technical discussion about infrastructure, safety and outcomes has instead become a distraction that is now directly impacting performance. From boardrooms to wards, and up into the centre of government, the truth remains simple. The NHS owns its [...]

  • The next frontier in precision oncology

    By Wolfgang Hackl, MD, CEO OncoGenomX, Allschwil, Switzerland Precision oncology is entering a new phase. Over the next 10-15 years, it is likely to evolve from a discipline focused mainly on molecular matching into one that is dynamic, predictive, and deeply integrated with tumour biology, causal reasoning, and advanced AI. For HealthTech innovators, clinicians, researchers, [...]

  • Helical raises US$10m for virtual AI lab

    Helical has announced a US$10 million seed round led by redalpine with participation from Gradient, BoxGroup, Frst and notable angels including Aidan Gomez (CEO Cohere), Clement Delangue (CEO HuggingFace) and footballer Mario Goetze. The Helical virtual AI lab for pharma is an application layer that turns biological foundation models into decision-ready, reproducible in-silico discovery workflows. [...]

  • AI tool to predict which NHS bowel cancer patients will respond to new drug

    A new AI tool could show which advanced bowel cancer patients will respond to bevacizumab, a drug recently introduced by the NHS. Researchers at London’s Institute of Cancer Research (ICR) and the RCSI University of Medicine and Health Sciences in Dublin developed the PhenMap tool with the goal of sparing potentially thousands of patients from [...]

  • Boston Scientific’s FARAPULSE PFA shows 65% efficacy in persistent AF

    A late-breaking presentation at EHRA 2026 reaffirmed the safety and effectiveness of Boston Scientific’s FARAPULSE Pulsed Field Ablation (PFA) Platform. One-year outcomes in 49 persistent atrial fibrillation (AF) patients treated with the FARAPULSE Pulsed Field Ablation Platform, using the FARAWAVE PFA Catheter, demonstrated favourable efficacy and safety outcomes, as well as predictable and efficient procedural [...]

  • Eka Ventures closes €91.5 million Fund II

    Eka Ventures has closed its €91.5m Fund II to back UK startups in health, wellbeing and sustainability. According to Eka, the raise establishes it as the UK’s largest early-stage impact VC, investing in companies that deliver both commercial and societal benefits in health, wellbeing and sustainability. The oversubscribed fund has been backed by leading limited [...]

  • Digital tool aims to promote later-life bladder health

    Researchers have developed a digital tool designed to promote bladder health in adults aged 50 and over. A team from the University of Manchester, Lithuanian Sports University and the University of Vic in Spain developed the tool, called KOKU Bladder. The initiative brings together evidence-based education, pelvic floor muscle training, behaviour change techniques and gamification [...]

  • Who will be crowned health tech leader of the year?

    The Health Tech World Awards are set to once again celebrate the trailblazers and breakthroughs transforming health outcomes around the world. This year's Leader of the Year award recognises an extraordinary individual who has shown genuine vision in pushing healthcare forward through the power of technology. The winning candidate will have left a tangible mark, [...]

  • Lessons from HIMSS: AI will not fix healthcare: Informed leadership might

    By Gil Bashe, FINN Partners Chair Global Health and Purpose, and a Health Tech World Correspondent. Bashe is the author of Healing the Sick Care System: Why People Matter At the HIMSS Global Health Conference, the conversation around artificial intelligence felt different this year. Not quieter, but more grounded. The industry is moving beyond fascination [...]

  • Sleep Cycle and Revolut extend partnership

    AI sleep technology company,Sleep Cycle and global fintech company Revolut, have signed a partnership agreement valid to June 2027. This renewed collaboration strengthens a long-term commitment, where Sleep Cycle continues to be part of Revolut’s exclusive partnership offerings, reaching millions of eligible Revolut users. Erik Jivmark, CEO at Sleep Cycle, said: “Revolut has been a [...]